Elsevier

Cryobiology

Volume 96, October 2020, Pages 1-11
Cryobiology

Review of non-permeating cryoprotectants as supplements for vitrification of mammalian tissues

https://doi.org/10.1016/j.cryobiol.2020.08.012Get rights and content

Abstract

Vitrification of mammalian tissues is important in the areas of human assisted reproduction, animal reproduction, and regenerative medicine. Non-permeating cryoprotectants (CPAs), particularly sucrose, are increasingly used in conjunction with permeating CPAs for vitrification of mammalian tissues. Combining non-permeating and permeating CPAs was found to further improve post-thaw viability and functionalities of vitrified mammalian tissues, showing the potential applications of such tissues in various clinical and veterinary settings. With the rising demand for the use of non-permeating CPAs in vitrification of mammalian tissues, there is a strong need for a timely and comprehensive review on the supplemental effects of non-permeating CPAs toward vitrification outcomes of mammalian tissues. In this review, we first discuss the roles of non-permeating CPAs including sugars and high molecular weight polymers in vitrification. We then summarize the supplemental effects of non-permeating CPAs on viability and functionalities of mammalian embryos, and ovarian, testicular, articular cartilage, tracheal, and kidney tissues following vitrification. Lastly, challenges associated with the use of non-permeating CPAs in vitrification of mammalian tissues are briefly discussed.

Introduction

Cryopreservation is a method of preserving living cells and tissues over a long term using subzero temperatures [54,113]. There are two cryopreservation approaches, which are slow freezing and vitrification [112]. Slow freezing involves low cooling rates (e.g., 1 °C/min) to freeze a liquid containing living cells or tissues using a programmable freezer [45]. Vitrification involves an ice-free approach to convert a liquid containing living cells or tissues into a glass-like amorphous solid either using high concentrations of cryoprotectants (CPAs) or rapidly cooling with or without the use of a cryodevice (e.g., cryovial, plastic straw, and cryotop) [83]. Over the past decade, vitrification is becoming increasingly more utilized for the cryopreservation of mammalian tissues. Compared to slow freezing, vitrification aims to avoid ice formation that is harmful to mammalian tissues [50,83]. It has been demonstrated that the formation of extracellular or intracellular ice in mammalian smooth muscle, articular cartilage, and kidney tissues is severely damaging [47,76,77]. Several studies reported that vitrification is better than slow freezing in preserving viability and functional properties of different types of mammalian tissues such as embryos, and ovarian, testicular, and articular cartilage tissues [36,39,89,99,109,114]. Moreover, vitrification is cost-effective as it does not require an expensive programmable freezer [5,58]. To date, vitrification of mammalian tissues is important in the fields of human assisted reproduction, animal reproduction, and regenerative medicine.

In general, vitrification requires a viscous and highly concentrated (6–8 M) cryoprotectant to avoid ice formation during cooling [54,116]. CPAs can be divided into permeating CPAs and non-permeating CPAs. Permeating CPAs, such as ethylene glycol (EG), dimethyl sulfoxide (Me2SO), propylene glycol (PG), and glycerol, are small molecules that can penetrate the plasma membrane and form hydrogen bonds with water molecules to lower the freezing point thereby preventing intracellular and extracellular ice formation [53,94]. The literature on the properties and roles of permeating CPAs in cryopreservation is readily available [29,37,44,[53], [54], [55]]. It is necessary to have at least one permeating CPA for vitrification of mammalian tissues. Because a high concentration of one permeating CPA is extremely cytotoxic, vitrification usually uses a combination of two or more permeating CPAs to lower the concentration of each CPA to reduce cytotoxicity [4,32,108]. Combination of different permeating CPAs has successfully vitrified embryos, and ovarian, testicular, and articular cartilage tissues [10,23,43,99,107]. Despite these positive outcomes, researchers are still concerned with optimizing post-thaw cell viability and functionalities to prevent poor clinical outcomes and faulty reproduction. Therefore, it may be possible that a combination of non-permeating and permeating CPAs in vitrification of mammalian tissues will further diminish cytotoxic effects of permeating CPAs and improve the clinical outcomes of vitrification [70].

Non-permeating CPAs are large molecules that do not penetrate the plasma membrane and remain in the extracellular compartment during cooling to promote glass formation [48]. Non-permeating CPAs include sugars (e.g., sucrose and trehalose) and high molecular weight (MW) polymers (e.g., polyvinyl pyrrolidone and Ficoll) [5]. Compared to permeating CPAs, they are relatively less cytotoxic. Their addition contributes to viscosity and tonicity, allowing lower concentrations of permeating CPAs to be used without compromising vitrification properties [5]. Some studies reported that combining non-permeating and permeating CPAs further improved post-thaw viability and functionalities of vitrified embryos and ovarian tissues [3,24,67,69,115]. For example, in one study, vitrification medium containing sucrose, EG, and Me2SO was found to enhance post-thaw follicular viability in ovarian tissues compared to vitrification medium without sucrose [69]. Despite promising outcomes, many challenges associated with incorporation of non-permeating CPAs in vitrification of mammalian tissues remain to be addressed.

Several review articles are focused on vitrification of embryos and ovarian tissues [5,70,75]. However, there is no review focused on the supplemental effects of non-permeating CPAs toward vitrification outcomes of mammalian tissues, including embryos, and reproductive, cartilage, and kidney tissues. In view of the escalating demand for the use of non-permeating CPAs in vitrification of mammalian tissues, there is a strong need for a timely review on the supplemental effects of non-permeating CPAs toward vitrification outcomes of mammalian tissues. In this review, the roles of non-permeating CPAs including sugars and high MW polymers in vitrification are first discussed. The supplemental effects of non-permeating CPAs on viability and functionalities of mammalian embryos, and ovarian, testicular, articular cartilage, tracheal, and kidney tissues following vitrification are subsequently reviewed. Lastly, the challenges associated with the use of non-permeating CPAs in vitrification of mammalian tissues are briefly discussed.

Section snippets

Sugars

Some sugars, such as sucrose, trehalose, and raffinose, have been used in vitrification of mammalian tissues [15,71,73]. Sucrose is a disaccharide consisting of glucose and fructose. Sucrose is found in nectars, fruits, and roots of many plants [20]. Trehalose is a disaccharide composed of two glucose moieties. It is present in some animals, insects, plants, fungi, and bacteria and used by these organisms to overcome freezing and dehydration [22]. Raffinose is a trisaccharide consisting of

Embryos

Cryopreservation of mammalian embryos is important in three major areas. First, it assists reproduction for couples with infertility problems [56]. Second, it conserves genetic resources of livestock mammals for reproduction to maintain food supplies, especially meat and milk, and wild mammals threatened with extinction [2,98]. Third, it also conserves genetic resources of laboratory mammals to maintain production of laboratory mammals for preclinical studies, such as normal and mutant mouse

Challenges associated with the use of non-permeating CPAs in vitrification of mammalian tissues

There are several challenges associated with the use of non-permeating CPAs in vitrification of mammalian tissues. First of all, non-permeating CPAs, particularly sugars, can cause excessive dehydration to mammalian tissues and compromise vitrification properties of permeating CPAs when used in high concentrations. Therefore, concentration of sugars in both vitrification and warming media should be optimized to minimize freezing injury to cells.

To date, non-permeating CPAs have been clinically

Conclusions

Non-permeating CPAs play many roles in supporting permeating CPAs in vitrification of mammalian tissues. While contributing to viscosity needed for vitrification, addition of non-permeating CPAs in vitrification media replaces a portion of permeating CPAs to lower concentration of each permeating CPA, reducing the cytotoxic effects of permeating CPAs. Moreover, addition of sugars in both vitrification and warming media protects cells from physical damage by extracellular ice and restricts

Declaration of competing interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

N.M. Jomha and J.A.W. Elliott are inventors on US Patent No. 8,758,988: N.M. Jomha, L.E. McGann, J.A.W. Elliott, G. Law, F. Forbes, A. Abazari, B. Maghdoori, and A. Weiss, Cryopreservation of articular cartilage (2014).

Acknowledgements

This work was supported by the Edmonton Orthopaedic Research Committee. J.A.W. Elliott holds a Canada Research Chair in Thermodynamics.

References (116)

  • M. Curaba et al.

    Cryopreservation of prepubertal mouse testicular tissue by vitrification

    Fertil. Steril.

    (2011)
  • I.A. de Graaf et al.

    Cryopreservation of rat precision-cut liver and kidney slices by rapid freezing and vitrification

    Cryobiology

    (2007)
  • P. dos Santos Neto et al.

    Cryotolerance of Day 2 or Day 6 in vitro produced ovine embryos after vitrification by Cryotop or Spatula methods

    Cryobiology

    (2015)
  • G.D. Elliott et al.

    Cryoprotectants: a review of the actions and applications of cryoprotective solutes that modulate cell recovery from ultra-low temperatures

    Cryobiology

    (2017)
  • S.S. Gouk et al.

    Cryopreservation of mouse testicular tissue: prospect for harvesting spermatogonial stem cells for fertility preservation

    Fertil. Steril.

    (2011)
  • A.-N. Ha et al.

    Development of a modified straw method for vitrification of in vitro-produced bovine blastocysts and various genes expression in between the methods

    Cryobiology

    (2014)
  • A. Hayashi et al.

    Development of an efficient vitrification method for chondrocyte sheets for clinical application

    Regener. Ther.

    (2020)
  • M. Hayashi et al.

    Influence of freezing with liquid nitrogen on whole-knee joint grafts and protection of cartilage from cryoinjury in rabbits

    Cryobiology

    (2009)
  • L. Huang et al.

    Cryopreservation of human ovarian tissue by solid-surface vitrification

    Eur. J. Obstet. Gynecol. Reprod. Biol.

    (2008)
  • A. Hubel

    Parameters of cell freezing: implications for the cryopreservation of stem cells

    Transfus. Med. Rev.

    (1997)
  • J. Huebinger et al.

    Direct measurement of water states in cryopreserved cells reveals tolerance toward ice crystallization

    Biophys. J.

    (2016)
  • T.H. Jang et al.

    Cryopreservation and its clinical applications

    Integr. Med. Res.

    (2017)
  • N.M. Jomha et al.

    Vitrification of intact human articular cartilage

    Biomaterials

    (2012)
  • N.M. Jomha et al.

    Cryoprotectant agent toxicity in porcine articular chondrocytes

    Cryobiology

    (2010)
  • J.O.M. Karlsson et al.

    Long-term storage of tissues by cryopreservation: critical issues

    Biomaterials

    (1996)
  • Y. Kim et al.

    Successful vitrification of bovine blastocysts on paper container

    Theriogenology

    (2012)
  • J. Lee et al.

    Establishment of an improved vitrification protocol by combinations of vitrification medium for isolated mouse ovarian follicles

    Theriogenology

    (2018)
  • F.O. Lunardi et al.

    Ovine secondary follicles vitrified out the ovarian tissue grow and develop in vitro better than those vitrified into the ovarian fragments

    Theriogenology

    (2016)
  • K. Matsumura et al.

    Polyampholytes as low toxic efficient cryoprotective agents with antifreeze protein properties

    Biomaterials

    (2009)
  • M. Moniruzzaman et al.

    Development of vitrified porcine primordial follicles in xenografts

    Theriogenology

    (2009)
  • R. Morató et al.

    New device for the vitrification and in-straw warming of in vitro produced bovine embryos

    Cryobiology

    (2014)
  • L. Mouttham et al.

    The preservation of vital functions in cat ovarian tissues during vitrification depends more on the temperature of the cryoprotectant exposure than on the sucrose supplementation

    Cryobiology

    (2016)
  • Z.P. Nagy et al.

    Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment

    Fertil. Steril.

    (2020)
  • A. Nakashima et al.

    Optimization of a novel nylon mesh container for human embryo ultrarapid vitrification

    Fertil. Steril.

    (2010)
  • I. Onari et al.

    Vitreous preservation of articular cartilage from cryoinjury in rabbits

    Cryobiology

    (2012)
  • Y. Panagiotidis et al.

    Open versus closed vitrification of blastocysts from an oocyte-donation programme: a prospective randomized study

    Reprod. Biomed. Online

    (2013)
  • R. Parnpai et al.

    Vitrification of buffalo oocytes and embryos

    Theriogenology

    (2016)
  • D.E. Pegg et al.

    Cryopreservation of articular cartilage. Part 2: mechanisms of cryoinjury

    Cryobiology

    (2006)
  • D.E. Pegg et al.

    Fractures in cryopreserved elastic arteries

    Cryobiology

    (1997)
  • C. Puts et al.

    Polyethylene glycol protects primary hepatocytes during supercooling preservation

    Cryobiology

    (2015)
  • M. Romek et al.

    Changes of lipid composition in non-cultured and cultured porcine embryos

    Theriogenology

    (2010)
  • J. Sanchez-Osorio et al.

    Vitrification and warming of in vivo–derived porcine embryos in a chemically defined medium

    Theriogenology

    (2010)
  • G.E. Seidel

    Modifying oocytes and embryos to improve their cryopreservation

    Theriogenology

    (2006)
  • S. Seki et al.

    Vitrification of one-cell mouse embryos in cryotubes

    Cryobiology

    (2018)
  • M. Sheikhi et al.

    Preservation of human ovarian follicles within tissue frozen by vitrification in a xeno-free closed system using only ethylene glycol as a permeating cryoprotectant

    Fertil. Steril.

    (2013)
  • H. Shi et al.

    Animal models of tracheal allotransplantation using vitrified cryopreservation

    J. Thorac. Cardiovasc. Surg.

    (2009)
  • A. Shirazi et al.

    Vitrification of in vitro produced ovine embryos at various developmental stages using two methods

    Cryobiology

    (2010)
  • K. Akiyama et al.

    Calf production from vitrified bovine sexed embryos following in‐straw dilution

    Anim. Sci. J.

    (2010)
  • A. Al Yacoub et al.

    Is sucrose required in open pulled straw (OPS) vitrification of mouse embryos?

    Cryo-Letters

    (2013)
  • J. Ali et al.

    Design of vitrification solutions for the cryopreservation of embryos

    Reproduction

    (1993)
  • Cited by (35)

    • The effect of sucrose supplementation on chondrocyte viability in porcine articular cartilage following vitrification

      2022, Cryobiology
      Citation Excerpt :

      The concentration of sucrose in the vitrification medium in this study was 0.5 M as this concentration was commonly added in vitrification media for mammalian tissues [48]. CPA removal was done in descending concentrations of sucrose in the warming medium starting from 1 M followed by 0.5 M and finally 0 M [48]. Fig. 1A displays an AC slice for the fresh control with chondrocyte viability greater than 80%.

    • Advances in storage of poultry semen

      2022, Animal Reproduction Science
      Citation Excerpt :

      The inclusion of a combination of permeating and non-permeating cryoprotectant to an avian semen diluent result in protection of cryopreserved cells through having effects on different intracellular processes. With inclusion of non-permeating substances to a semen diluent, there is an osmotic pressure that leads to a lesser freezing temperature of the medium and lesser extracellular ice formation (Yong et al., 2020). The effect of small molecular weight cryoprotectants, in turn, is associated with a lesser intracellular ice formation.

    View all citing articles on Scopus
    View full text